Biological evaluation identified compound 6b as a potent EGFR inhibitor against MCF-7 cells, suggesting potential in anticancer therapies.
Design, synthesis, and biological evaluation of pyrazoline–pyrrole hybrids led to the identification of compound 6b as a potent EGFR inhibitor with significant antiproliferative activity against MCF-7 cells.
No takes yet. Share an insight, caveat, or question.
Alturki et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: